and 24 hours after the procedure. ST resolution was estimated at 90 minutes in the worst lead.
BACKGROUND Bifurcation (BF) lesions remain a challenging lesion and often associated with lower success rates. The aim of this study is to evaluate the impact BF intervention in acute myocardial infarction (AMI) on the angiographic and clinical outcomes of Asian population.
METHODS A total of 903 patients (pts) were underwent percutaneous coronary intervention (PCI) for AMI between January 2004 and April 2009. Patients were divided into two groups according to presence of a BF lesion in the infarct-related artery: BF group (n¼ 332) and non BF group (n¼571). BF lesions were defined if a side branch (SB) diameter was !2.0 mm.
RESULTS BF group had more male gender, higher incidence of non ST elevation MI(NSTEMI, 51.5% vs. 60.4%, p¼0.01), higher incidences of culprit lesion in left anterior descending artery, left circumflex artery, and left main as compared with non BF group. However, the level of peak values of cardiac enzyme and left ventricular ejection (LVEF) were similar between the two groups. The six months angiographic outcomes and the cumulative clinical outcomes up to two years including total death, cardiac death, MI, and major adverse cardiac events (MACE) were similar between the two groups. However, BF group had higher incidence of target lesion revascularization (TLR), target vessel revascularization (TVR) and TVR-MACEs as compared with non BF group (Table) .
CONCLUSION Despite BF intervention in AMI is challenging, the six months angiographic outcomes and 2 years clinical outcomes were similar between the two groups. However, BF intervention in AMI had higher incidence of repeat revascularization. combination therapy group than that of control group (Figure 3, 4) . Six months clinical follow-up was obtained in 552 patients. Events rates are presented in Table 3 . There were 6(6.3%) events (1 death, 2 non-fatal MIs and 3 revascularizations) in combination therapy group, significantly lower than 12(13.2%) events (4 deaths, 3 non-fatal MIs and 5 revascularizations) in control group.
CONCLUSION Our study discovered that using no-flow risk prediction model to screen AMI patients who had been suffered with high risk of no-reflow, and pretreated them with combination treatment could significantly lower the incidence of no-reflow, and further improved the prognosis.
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BACKGROUND Revascularization of culprit vessel is the goal of primary percutaneous coronary intervention (PCI) in patients with acute ST elevation myocardial infarction (STEMI) and multivessel disease (MVD) without hemodynamic compromise. Although concurrent revascularization of significant non-culprit lesions during index procedure may reduce infarct size and health care costs; however its safety and feasibility is still debatable. We compare short and long term outcome of Staged versus Multivessel primary PCI in hemodynamically stable STEMI patients with MVD.
METHODS A single-center, open label, randomized prospective study including 50 patients with acute STEMI and one or more significant non-culprit lesions of either type A or B (high peri-procedural revascularization success rate). Patients were randomized to either culprit lesion PCI during index procedure followed by PCI to other significant lesions in a later session within 60 days (Staged revascularization group, SR) or multi-vessel revascularization during index procedure (MVR). Primary outcomes were composite of death, MI requiring hospitalization (excluding periprocedural MI), target or non-target vessel revascularization (PCI or coronary artery bypass grafting), and decreased renal function 3-5 days following administration of radiographic contrast dye. Patients were followed over a period of 12 months. CONCLUSION We may conclude from this pilot study that multivessel intervention during primary PCI is feasible and safe compared to a staged PCI approach when nonculprit lesions have high rate of peri-procedural success. To our knowledge, this is the first pilot trial in literature that suggest using lesion criteria and rate of periprocedural success to decide about the appropriate approach during primary PCI for patients with acute STEMI and MVD. 
RESULTS

